Drug Database
Back to search

Poland· PL-100385936

Cykloftyal

A cyclopentolate product containing cyclopentolati hydrochloridum, registered in Poland by Verco S.A.. The same ATC class is registered in 16 of our 19 countries.

ATC S01FA04

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedCykloftyalATCS01FA04REGISTER NO.PL-100385936PACKS LISTED1CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about cyclopentolati hydrochloridumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Cyclopentolate is registered in 16 of 19 countries.

Countries holding a registration under ATC S01FA04 (cyclopentolate), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 8 of them publish a price we can compare per daily dose
Search cyclopentolate products by name

Cyclopentolate · ATC S01FA04

16 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Cyclopentolati hydrochloridum
Manufacturer
Verco S.A.
Country
Poland (PL)
ATC code
S01FA04
ATC class
Cyclopentolate
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 1

  • gtin
    05909991467098

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

3 interactions on record for cyclopentolate.

Graded by severity as the source publishes them — 3 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check cyclopentolate against other medicinesHow interaction checks work

Cyclopentolate · interactions on record

3 records

  • 3 moderate

Most severe, free to view

  • PhenylephrineC01CA06moderate
  • PhysostigmineS01EB05moderate
  • PhysostigmineV03AB19moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Cyclopentolate in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All cyclopentolate products

Authorised across Europe · EMA

The same active substance is authorised in 22 EEA countries. Names it is sold under:

  • Belgium · Cyclogyl, Minims Cyclopentolaathydrochloride Bausch + Lomb Ireland Limited
  • Bulgaria · Цикловижън
  • Cyprus · Cyclogyl
  • Czechia · Cyclopentolate Olikla
  • Germany · Cyclopentolat Alcon, Zyklolat Edo
  • Denmark · Cyclogyl
  • Spain · Colirofta Ciclopléjico
  • Finland · Oftan Syklo
  • France · Skiacol
  • Greece · Cyclogyl
  • Hungary · Humapent
  • Ireland · Minims
  • Iceland · Cyclogyl
  • Italy · Ciclolux, Plegik
  • Lithuania · Cyclogyl
  • Luxembourg · Minims, Minims Cyclopentolate Chlorhydrate Bausch + Lomb Ireland Limited
  • Malta · Minims Cyclopentolate Hydrochloride Bausch + Lomb Ireland
  • Netherlands · Cyclogyl, Minims Cyclopentolaathydrochloride Bausch + Lomb Ireland Limited
  • Norway · Cyclopentolat Bausch + Lomb Ireland Limited
  • Portugal · Cicloplegicedol, Midriodavi
  • Sweden · Cyclogyl, Cyclopentolat Bausch & Lomb
  • Slovakia · Cyclopentolate Olikla

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/5f45f898-1ed6-4e2a-b30d-5f51becb2c88
GET /v1/drugs/5f45f898-1ed6-4e2a-b30d-5f51becb2c88?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Krople do oczu, roztwór",
  "source": "urpl",
  "strength": "10 mg/ml",
  "packaging": "05909991467098 ¦ Rp ¦ 142104\n1 butelka 5 ml",
  "substance": "Cyclopentolati hydrochloridum 10 mg/ml",
  "common_name": "Cyclopentolati hydrochloridum",
  "pl_product_id": "100385936",
  "pozwolenie_nr": "26671",
  "auth_procedure": "NAR",
  "authorisation_validity": "2026-10-12"
}
API referenceMCP serverPlans

See everything about cyclopentolate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console